Delivery Order SPE2DB24D9223-SPE2DB25FKEFB

Award Date 4/22/25
Potential Completion Date 5/13/25
Potential Value $49K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $81,895.60 firm fixed-price delivery order is for the supply of Keytruda 100 mg/4 ml vials, with an ultimate completion date of April 24, 2025. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue...
This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $47,651.39, is a delivery order for the supply of Keytruda 100 mg/4 ml vials. The contract has a firm fixed price and an ultimate completion date of May 13, 2025. DMS Pharmaceutical Group Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program,...
This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order valued at $90,245.65 for the supply of KEYTRUDA 100 MG/4 ML VIAL 4ML, a prescription medication. The contract has a firm fixed price and an ultimate completion date of June 4, 2025. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $24,568.74 firm fixed-price delivery order is for the supply of KEYTRUDA 100 MG/4 ML VIAL 4ML, a specialized oncology medication. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $81,895.60, is a firm fixed-price delivery order for the procurement of 4,567,422,449 units of the drug Keytruda (100 mg/4 ml vial, 4 ml). The contract has an ultimate completion date of March 19, 2025. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $121,887.13 firm fixed-price delivery order is for the supply of Keytruda 100 mg/4 ml vials. This award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which enables the agency to issue delivery orders for a...
This federal contract award is a delivery order for KEYTRUDA 100 MG/4 ML VIAL 4ML, awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $24,568.74 firm fixed-price contract has an ultimate completion date of March 24, 2025. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the DLA to issue...
The Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract worth $48,131.04 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of Keytruda 100 mg/4 mL vials with a completion date of June 6, 2024. This award is part of DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with DLA, valued up to $499,999,999, that enables the agency to issue delivery...
This federal contract award, valued at $81,895.60, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the supply of 4,567,379,133 units of Keytruda 100 mg/4 mL vial (4 mL). This award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group Inc. with the DLA under the SPE2DB program,...
This federal contract award, valued at $16,057.14, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the supply of Keytruda 100 mg/4 ml vial, with an ultimate completion date of November 5, 2024. DMS Pharmaceutical Group Inc. holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program,...
  • SPE2DB24D9223
    Indefinite Delivery Contract
  • SPE2DB24D9223-SPE2DB25FKEFB
    Delivery Order

This is a federal contract award by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $49,137.36, is for the delivery of Keytruda 100 mg/4 ml vials. The contract is a firm fixed-price delivery order with a completion date of May 13, 2025. DMS Pharmaceutical Group Inc. is an experienced federal contractor, holding a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery orders for a wide range of pharmaceutical products to support military health facilities. This contract award demonstrates DMS Pharmaceutical Group's ability to compete effectively for federal pharmaceutical contracts without set-aside designations, leveraging its status as a woman-owned small business.

Generated 7/22/25, 9:53 AM